DCF — LOYOLA UNIVERSITY MEDICAL CENTER
Enterprise Value: $-2.2B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-2.2B
Enterprise Value
$-699.7M
PV of Cash Flows
$-1.5B
PV of Terminal Value
$-2.4B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.4B | $-136.1M | -9.0% | $-197.3M | $-179.4M |
| Year 2 | $1.5B | $-125.3M | -8.0% | $-188.4M | $-155.7M |
| Year 3 | $1.5B | $-113.8M | -7.0% | $-178.7M | $-134.2M |
| Year 4 | $1.6B | $-109.3M | -7.0% | $-176.1M | $-120.3M |
| Year 5 | $1.6B | $-108.5M | -7.0% | $-177.4M | $-110.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-2.2B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.4B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.099204041075641
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5